Ensayos clínicos A continuación, se enumeran los ensayos clínicos actuales.91 estudios en Medicina cardiovascular (solo estudios abiertos). Filtra esta lista de estudios por sede, estatus, etc. Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE) Rochester, Minn. The purpose of this study is to evaluate comparisons between a hybrid program of center-based CR which incorporates mHealth remote case management technology (CON+) to a traditional center-based program alone (CON) as well as comparisons between home-based mHealth remote case management alone (HOM+) to a traditional center-based program (CON). International Bicuspid Aortic Valve Consortium (BAVCon) Rochester, Minn. Bicuspid aortic valve (BAV) disease is the most frequent congenital cardiac malformation, occurring in 0.5-1.2% of the US population. In young adults, it is generally a benign abnormality; but in older adults it is associated with thoracic aortic aneurysm or dissection in 20-30% of those with BAV. BAV is strongly associated with early development of aortic valve calcification or incompetence in >50% of BAV patients, and accounts for ~40% of the >30,000 aortic valve replacements (AVR) performed in the US each year. Yet, we know little of the etiology, cellular events and modifiers of progression of BAV to calcific aortic valve disease and we still do not understand the genetic cause(s) of BAV despite evidence for its high heritability. The Specific Aims of this study are: 1. To identify the genetic causes of bicuspid aortic valve disease and its associated thoracic aortic disease. 2. To identify potential pathways to predict the clinical course of BAV disease and for treating human BAV disease. To achieve these aims, we have created the International Bicuspid Aortic Valve Consortium (BAVCon), a consortium of institutions with cohorts of BAV patients and the expertise to fulfill the performance of these aims. Surgical Outcomes of Mitral Valve Repair Rochester, Minn. The purpose of this study is to learn more about early and late outcomes in patients after mitral valve repair. Is Our Microbiome a Predictor of Cardiac Risk Rochester, Minn. The purpose of this study is to compare the fecal microbiota of patients with mild, moderate and severe Coronary Artery Disease (CAD) by collecting stool and blood samples from patients undergoing coronary angiograms. Identification of Novel Genetic Variants and Biomarkers of Disease Progression in Arrhythmogenic Cardiomyopathy Rochester, Minn. The purpose of this study is to identify hereditary causes of cardiomyopathy. A Study to Evaluate Decision-support Interventions for Atrial Fibrillation (RED-AF) Rochester, Minn. The primary purpose of this study is to assess the comparative effectiveness of the following 4 approaches to promote high-quality SDM for at-risk patients with AF: a PDA alone, (2) an EDA alone, (3) a combination of a PDA and an EDA, and (4) control with neither a PDA nor an EDA. A Study of the Mayo Clinic College of Medicine Ultrasound System Rochester, Minn. The purpose of this study is is to assess the EPIQ-Affiniti and NG Compact ultrasound systems in a clinical environment and collect clinical data and feedback when compared to the site’s standard ultrasound system. Exercise during Heart Cath in CHD Patients Rochester, Minn. The purpose of this study is to compare the difference in the ability to detect blood flow abnormalities between invasive assessments performed at rest versus exercise. Genotype-Phenotype Correlation in Cardiovascular Disease Rochester, Minn. This research study is being done to help characterize cardiovascular disease and improve diagnostic tests. OBJECTIVES To understand the pathogenesis, molecular mechanisms, and disease progression of heritable cardiovascular disease To evaluate the incidence of occult heritable cardiovascular disease in various populations. To correlate imaging and pathological phenotype with genotype to the ends described above. A Study to Assess the Role of Biomarkers in Risk Stratification in Adults with Congenital Heart Disease Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, and to determine if temporal changes in biomarker levels can provide a better risk prediction compared to biomarker assay obtained at baseline. Numeración de páginas Estudios clínicos AnteriorPágina anterior Ir a página 11 Ir a página 22 Ir a página 33 Ir a página 44 Ir a página 55 SiguientePróxima página Solicite una consulta Conocimientos y categoríasInvestigación March 16, 2024 Comparte en: FacebookTwitter U.S. News & World Report reconoce a Mayo Clinic de Rochester, Minnesota, como uno de los mejores hospitales del país para cardiología y cirugía cardíaca en el período 2024-2025. Obtén más información sobre este gran honor Medicina cardiovascularPágina inicialdel departamentoSeccionesDescripción generalSolicita una consultaAnálisis y procedimientosAfecciones cardiovasculares que se tratanMédicosGrupos especializadosConocimientos y categoríasEnsayos clínicosInvestigaciónHistorias de pacientesCostos y seguroNoticias de Mayo ClinicRemisiones Investigación: los pacientes son la prioridad Mostrar la transcripción Para video Investigación: los pacientes son la prioridad [SUENA MÚSICA] Dr. Joseph Sirven, profesor de Neurología, Mayo Clinic: La misión de Mayo se centra en el paciente. La prioridad es el paciente. Aquí, la misión y la investigación se hacen para progresar en la forma de ayudar mejor al paciente y para asegurarnos de que el paciente sea la prioridad en la atención médica. De muchas maneras, esto equivale a un ciclo. Puede comenzar con algo tan simple como una idea que se desarrolla en un laboratorio, se traslada a la atención directa del paciente y, si todo sale bien y resulta útil o beneficioso, pasa a ser el método estándar. Creo que una de las características tan singulares de la forma de investigar en Mayo es la concentración en el paciente, y es lo que realmente le ayuda a captar la atención de todos. SeccionesSolicita una consultaDescripción generalAnálisis y procedimientosAfecciones cardiovasculares que se tratanMédicosGrupos especializadosConocimientos y categoríasEnsayos clínicosInvestigaciónHistorias de pacientesCostos y seguroNoticias de Mayo ClinicRemisiones ORG-20121929 Centros y departamentos médicos Medicina cardiovascular